TeselaGen

company

About

TeselaGen Biotechnology develops DNA design and assembly tools for biology.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$180K
Industries
Artificial Intelligence,Biotechnology,Genetics,Information Technology,Life Science,Software
Founded date
Jun 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants.

Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.59M
TeselaGen has raised a total of $1.59M in funding over 2 rounds. Their latest funding was raised on Sep 4, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 4, 2014 Grant $1.26M 1 National Science Foundation Detail
Jan 1, 2013 Grant $150K 1 National Science Foundation Detail
Jun 13, 2012 Grant $180K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
1
TeselaGen is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant